Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2404007 | Vaccine | 2011 | 6 Pages |
Abstract
This study reports effectiveness of trivalent influenza vaccine (TIV) against confirmed pandemic influenza infection in England using a retrospective test-negative case–control study. Cases and controls were frequency matched by age, swabbing-week and region. On univariable and multivariable analysis adjusted for underlying clinical risk factors, cases were no more or less likely than controls to be vaccinated with 2008–09 or 2007–08 season TIV. Adjusted vaccine effectiveness for the former was −6% (−43% to 22%). Vaccine effectiveness did not differ significantly by age-group or hospitalisation status. There was no evidence prior vaccination with TIV significantly altered subsequent risk of pandemic influenza H1N1 2009 infection.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Richard Pebody, Nick Andrews, Pauline Waight, Rashmi Malkani, Christine McCartney, Joanna Ellis, Elizabeth Miller,